These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 870572)

  • 1. Demonstration of gastric glucagon hypersecretion in insulin-deprived alloxan-diabetic dogs.
    Blazquez E; Muñoz-Barragan L; Patton GS; Dobbs RE; Unger RH
    J Lab Clin Med; 1977 May; 89(5):971-7. PubMed ID: 870572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric A-cell function in normal dogs.
    Muñoz-Barragan L; Blazquez E; Patton GS; Dobbs RE; Unger RH
    Am J Physiol; 1976 Oct; 231(4):1057-61. PubMed ID: 984193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric A-cell function in insulin-deprived depancreatized dogs.
    Blazquez E; Muñoz-Barragan L; Patton GS; Orci L; Dobbs RE; Unger RH
    Endocrinology; 1976 Nov; 99(5):1182-8. PubMed ID: 991814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of glucagon deficiency in the Houssay phenomenon of dogs.
    Nakabayashi H; Dobbs RE; Unger RH
    J Clin Invest; 1978 May; 61(5):1355-62. PubMed ID: 659597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of gastric glucagon secretion by epinephrine administration in dogs.
    Blázquez E; Muñoz-Barragán L
    Rev Esp Fisiol; 1990 Sep; 46(3):231-6. PubMed ID: 2091148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic and gastric somatostatin release in response to intragastric and intraduodenal nutrients and HCl in the dog.
    Schusdziarra V; Harris V; Conlon JM; Arimura A; Unger R
    J Clin Invest; 1978 Sep; 62(3):509-18. PubMed ID: 690183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of glucose and insulin on glucagon secretion in alloxan diabetic rats.
    Tanese T; Yokoyama J; Narimiya M; Tajima N; Yamada H; Ikeda Y; Abe M
    Horm Metab Res; 1980 Jul; 12(7):290-3. PubMed ID: 6995248
    [No Abstract]   [Full Text] [Related]  

  • 8. Origin of peripheral venous hypersomatostatinemia in alloxan-diabetic dogs.
    Schusdziarra V; Rouiller D; Harris V; Unger RH
    Endocrinology; 1981 Oct; 109(4):1107-16. PubMed ID: 6116595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of glucose turnover during exercise in pancreatectomized, totally insulin-deficient dogs. Effects of beta-adrenergic blockade.
    Bjorkman O; Miles P; Wasserman D; Lickley L; Vranic M
    J Clin Invest; 1988 Jun; 81(6):1759-67. PubMed ID: 3290252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics.
    Raskin P; Fujita Y; Unger RH
    J Clin Invest; 1975 Nov; 56(5):1132-8. PubMed ID: 1184740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FK-614, a selective peroxisome proliferator-activated receptor gamma agonist, improves peripheral glucose utilization while decreasing hepatic insulin extraction in alloxan-induced diabetic dogs.
    Uchino H; Kim T; Lam TK; Yoshii H; Klement P; Williams W; Kawamori R; Giacca A
    Metabolism; 2005 Sep; 54(9):1250-8. PubMed ID: 16125538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of arginine vasopressin in diabetes-associated increase in glucagon secretion.
    Yibchok-anun S; Abu-Basha EA; Yao CY; Panichkriangkrai W; Hsu WH
    Regul Pept; 2004 Nov; 122(3):157-62. PubMed ID: 15491785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a role of free fatty acids in the regulation of somatostatin secretion in normal and alloxan diabetic dogs.
    Wasada T; Howard B; Dobbs RE; Unger RH
    J Clin Invest; 1980 Sep; 66(3):511-6. PubMed ID: 6105166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between closed-loop portal and peripheral venous insulin delivery systems for an artificial endocrine pancreas.
    Sekigami T; Shimoda S; Nishida K; Matsuo Y; Ichimori S; Ichinose K; Shichiri M; Sakakida M; Araki E
    J Artif Organs; 2004; 7(2):91-100. PubMed ID: 15309676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Paradoxical hyperglucagonemia after oral administration of glucose in diabetic dogs. Impact of the cholinergic nervous system].
    Hillaire-Buys D; Ribes G; Gross R; Loubatières-Mariani MM
    C R Seances Soc Biol Fil; 1987; 181(6):677-82. PubMed ID: 2970286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressive effect of secretin upon pancreatic alpha cell function.
    Santeusanio F; Faloona GR; Unger RH
    J Clin Invest; 1972 Jul; 51(7):1743-9. PubMed ID: 4555784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposing actions of glucagon and insulin on splanchnic d cell function.
    Kawai K; Unger RH
    J Clin Invest; 1983 Mar; 71(3):721-5. PubMed ID: 6131079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of extrapancreatic glucagon to arginine in dogs.
    Ohneda A; Kobayashi T; Nihei J; Umezu M; Sakai T; Sanoyama K
    Tohoku J Exp Med; 1979 Sep; 129(1):45-54. PubMed ID: 494257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon secretion in rats with non-insulin-dependent diabetes: an in vivo and in vitro study.
    Giroix MH; Portha B; Kergoat M; Picon L
    Diabete Metab; 1984 Jan; 10(1):12-7. PubMed ID: 6724097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Extrapancreatic glucagon: experimental findings and clinical significance].
    Lefebvre PJ; Luyckx AS
    Journ Annu Diabetol Hotel Dieu; 1978; ():195-207. PubMed ID: 651097
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.